Stocks · Korea
000520
KOSPI
Samil Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+4.92%
1M+40.30%
3M+24.71%
6M-20.65%
1Y-19.30%
YTD-13.31%
52W high12,860원
52W low5,500원
From 52W high-33.67%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,797억 | 40억 | -28,287,010원 | 2.2% |
| 2023 | 1,963억 | 65억 | 17억 | 3.3% |
| 2024 | 2,197억 | 1억 | -56억 | 0.1% |
| 2025 | 2,103억 | -222억 | -347억 | -10.6% |
| Quarterly | ||||
| 2024 4Q | 578억 | -29억 | -36억 | -5.0% |
| 2025 1Q | 523억 | -54억 | -91억 | -10.3% |
| 2025 2Q | 538억 | -31억 | -65억 | -5.8% |
| 2025 3Q | 512억 | -52억 | -79억 | -10.1% |
| 2025 4Q | 530억 | -86억 | -112억 | -16.2% |
| 2026 1Q | 525억 | -84억 | -108억 | -15.9% |
Company
Address: 서울특별시 서초구 효령로 155 (방배동, 삼일제약 사옥)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-11주요사항보고서(전환사채권발행결정) Major
- 2026-05-15분기보고서 (2026.03)
- 2026-03-18사업보고서 (2025.12)
- 2026-02-26주요사항보고서(자기주식처분결정) Major
- 2025-11-14분기보고서 (2025.09)
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
- 2025-04-11주요사항보고서(자기주식처분결정) Major
- 2025-04-11주요사항보고서(교환사채권발행결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.